Cognitive and psychiatric features of anti-NMDA receptor encephalitis
The Lancet Neurology. 2022-10-01; 21(10): 861-862
DOI: 10.1016/S1474-4422(22)00349-0
![PubMed](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2019/01/logoPubMed.png)
Read on PubMed
1. Lancet Neurol. 2022 Oct;21(10):861-862. doi: 10.1016/S1474-4422(22)00349-0.
Cognitive and psychiatric features of anti-NMDA receptor encephalitis.
Villéga F(1), Prüss H(2), van Elst LT(3), Groc L(4).
Author information:
(1)Université de Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience,
UMR 5297, Bordeaux F-33000, France; Department of Pediatric Neurology, CIC-0005,
University Children’s Hospital of Bordeaux, Bordeaux, France.
(2)German Center for Neurodegenerative Diseases Berlin, Berlin, Germany;
Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin
Berlin, Berlin, Germany.
(3)Department of Psychiatry and Psychotherapy, Medical Center-University of
Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
(4)Université de Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience,
UMR 5297, Bordeaux F-33000, France. Electronic address:
.
Comment on
Lancet Neurol. 2022 Oct;21(10):899-910.
Conflict of interest statement: We declare no competing interests.